Can Precision Medicine Work for Everyone? Tackling the Challenge of Healthcare Disparities

11:00 AM - 12:15 PM, Tuesday, June 9, 2020 ・ Room 11A
Precision medicine was supposed to deliver more targeted, personalized treatment to all patients — but as it rolls out, it is both highlighting and exacerbating disparities within the healthcare system. Studies have shown, for instance, that African-American cancer patients tend to have poorer outcomes than Caucasian patients, even when their tumors are less aggressive. A moment of reckoning has arrived, but are we ready to address inequities in healthcare? Are we even capable of doing so? In this panel discussion, experts will consider a range of different disparities in healthcare, from the above-mentioned example of cancer patients to the need for greater diversity in clinical trials and more. They will explore potential remedies for these problems and present promising advances from teams that are actively tackling this thorny issue.
Moderator
photo
CEO and President
Global Blood Therapeutics
Speakers
photo
Professor, Chair, and Director
University of Southern California
photo
Executive Vice President, Clinical, Regulatory & Legal Affairs
Tetra Therapeutics
photo
Head of Alliance & Advocacy Relations in Government Affairs; co-lead of Advancing Inclusive Research
Genentech